<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00349505</url>
  </required_header>
  <id_info>
    <org_study_id>CHIPOVAC1</org_study_id>
    <secondary_id>CSET 1058</secondary_id>
    <nct_id>NCT00349505</nct_id>
  </id_info>
  <brief_title>Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma</brief_title>
  <official_title>Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gustave Roussy, Cancer Campus, Grand Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gustave Roussy, Cancer Campus, Grand Paris</source>
  <brief_summary>
    <textblock>
      Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as
      consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated
      by surgery and a total of 6 cycles of platinum based chemotherapy.

      A second look operation is performed after treatment; during this second look secondary
      cytoreductive surgery is accepted without bowel resection.If none or milimetric peritoneal
      disease is obseved an intraperitoneal chemotherapy is achieve
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2004</start_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>67</enrollment>
  <condition>Epithelial Ovarian Carcinoma</condition>
  <condition>Figo Stage IIIC</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hyper thermic chemo + surgery</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy

        Exclusion Criteria:

          -  Patients ASA 3 patients with no residual tumor at first operation negative microscopic
             second look
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique ELIAS, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gustave Roussy, Cancer Campus, Grand Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominique ELIAS, MD, PhD</last_name>
    <phone>00 33 014-211-5441</phone>
    <email>elias@igr.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Annie REY</last_name>
    <phone>00 33 014-211-4137</phone>
    <email>rey@igr.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique ELIAS, MD,PhD</last_name>
      <phone>00 33 014-211-5441</phone>
      <email>elias@igr.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2006</study_first_submitted>
  <study_first_submitted_qc>July 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2006</study_first_posted>
  <last_update_submitted>October 5, 2006</last_update_submitted>
  <last_update_submitted_qc>October 5, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2006</last_update_posted>
  <keyword>previous treatment surgery + 6 cycles of platinum based chemotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Neoplasms, Glandular and Epithelial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

